Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma
Open Access
- 11 April 2023
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 15 (8) , 2970-2998
Abstract
The Ubiquitin-proteasome system (UPS) performs a crucial role in immune activation and tumorigenesis. Nevertheless, the comprehensive role of the ubiquitin-proteasome system in the low-grade glioma (LGG) tumor microenvironment (TME) remains unknown. Ubiquitination modification patterns in LGG patients and corresponding characteristics of tumor immune traits, CSC stemness, and cellular senescence were evaluated via a comprehensive analysis of 20 ubiquitination modification regulators. For quantification of the ubiquitination modification status of individual patients, the UM-score was constructed and associated with TME characteristics, clinical features, cancer stem cell stemness, cellular senescence, prognosis, and immunotherapy efficacy. We identified that alterations in multiple ubiquitination regulators are linked to patient survival and the shaping of the tumor microenvironment. We found two different styles of ubiquitination modification in patients with low-grade glioma (immune-inflamed differentiation and immune-exclude dedifferentiation), characterized by high and low UM-score, and the two regulatory patterns of ubiquitination modification on immunity, stemness feature, and cellular senescence. We demonstrate that the UM-score could forecast the subtype of LGG, the immunologic infiltration traits, the biological process, the stemness feature, and the cellular senescence trait. Notably, the UM-score was related to immunotherapeutic efficacy, implying that modifying ubiquitination modification patterns by targeting ubiquitination modification regulators or ubiquitination modification pattern signature genes to reverse unfavorable TME properties will provide new insights into cancer immunotherapy. This research indicated that the ubiquitin-proteasome system is crucial in the formation of TME complexity and multiformity. The UM-score can determine ubiquitination modification status in individual patients, bringing about more personalized and effective immunotherapeutic tactics.Keywords
This publication has 46 references indexed in Scilit:
- Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6APOncogene, 2016
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerMolecules, 2016
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)Annals of Oncology, 2016
- Reversing T-cell Dysfunction and Exhaustion in CancerClinical Cancer Research, 2016
- Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responsesInternational Immunology, 2016
- Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?Hepatology, 2015
- USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistanceNeuro-Oncology, 2015
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer ProgressionCell, 2013
- The family of ubiquitin‐conjugating enzymes (E2s): deciding between life and death of proteinsThe FASEB Journal, 2009
- Cooperative interaction between c-myc and bcl-2 proto-oncogenesNature, 1992